Mirae Asset Global ETFs Holdings
IPSC icon

Mirae Asset Global ETFs Holdings’s Century Therapeutics IPSC Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,447
Closed -$13.1K – 3120
2025
Q1 		$13.1K Buy
27,447
+1,170
+4% +$879 ﹤0.01% 3012
2024
Q4 		$26.5K Buy
26,277
+1,140
+5% +$1.55K ﹤0.01% 2980
2024
Q3 		$43K Buy
25,137
+13,748
+121% +$26.9K ﹤0.01% 2948
2024
Q2 		$29K Buy
+11,389
New +$36K ﹤0.01% 2874

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's IPSC Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Century Therapeutics (IPSC) in Q2 2025, closing a stake of 27,447 shares — an estimated $13.1K sold.

Mirae Asset Global ETFs Holdings first reported a position in IPSC in Q2 2024 and held it in 4 quarters. The position peaked at $43K in Q3 2024. 65 funds tracked by Wall St. Rank hold IPSC as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Century Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 27,447 Century Therapeutics shares in Q2 2025, an estimated $13.1K.
  • Mirae Asset Global ETFs Holdings first reported a position in Century Therapeutics in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's Century Therapeutics position peaked at $43K in Q3 2024.
  • 65 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.